DaVita is spending heavily on new software and AI to improve kidney care, but those costs could weigh on results before any payoff shows up. Demand for dialysis still looks steady over time, yet the business can get knocked around by events like illness outbreaks, storms, and operational disruptions.Read more
DaVita is trying to lift performance by cutting costs, using more tech in clinics, and expanding outside the US as demand for dialysis stays steady. But higher patient deaths, slow take-up of new treatments, clinic disruptions, and government payment pressure could still hold back growth.Read more
DaVita is betting that better tech and AI, plus more “whole patient” kidney care programs, can cut paperwork, improve scheduling and bring in steadier payments. The upside is a more resilient business even as kidney care rules and patient trends shift, but treatment disruptions and higher costs could slow the payoff.Read more
No trending discussion available.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
